Cell substrates. their use in the production of vaccines and other biologicals. Benefit-risk assessment
Dull, H.B.
Advances in Experimental Medicine and Biology 118: 187-193
1979
ISSN/ISBN: 0065-2598 PMID: 495265 Document Number: 144839
Document emailed within 1 workday
Related Documents
Grachev, V.; Magrath, D. 1989: Status of WHO concerning continuous cell lines as substrates for the production of biologicals Developments in Biological Standardization 70: 215-219Biggs, P.M. 1970: Production of pathogen free avian cell substrate for production of vaccines Laboratory Practice 19(1): 45-49
Majer, M. 1970: Cell-containing substrates and vaccine production Schweizerische Medizinische Wochenschrift 100(48): 2086-2089
Ochoa-Grullon, J.; Morado, C.; Macarron, P.; Freites, D.; Diaz, I.; Nuñez-Beltrán, M.; Rodriguez de la Peña, A.; Comins-Boo, A.; Llano Hernández, K.; Rodriguez, E.; Toledano, E.; Fernandez, B.; Sanchez-Ramόn, S.; Candelas, G. 2016: AB1007Recurrent Infection after Biologicals in Autoimmune Disease: Preliminary Results with Mucosal Vaccines Recurrent Infection after Biologicals in Autoimmune Disease: Preliminary Results with Mucosal Vaccines Annals of the Rheumatic Diseases 75(Suppl 2): 1246.1-1246
Glathe, H.; Abel, C. 1977: Evidence of tumorigenic activity of candidate cell substrates in vaccine production by use of antilymphocyte serum Developments in Biological Standardization 34: 145-148
Bruckner, L.; Stäuber, N.; Brechtbühl, K.; Hofmann, M.A. 1996: Detection of extraneous agents in vaccines using the polymerase chain reaction of Newcastle disease virus in poultry biologicals Developments in Biological Standardization 86: 175-182
Rubinow, A.; Leshem-Rubinow, E. 2007: Risk-benefit assessment in determining decision-making capacity Harefuah 146(7): 563
Morton, D.B.; Hanenberg, E.; Hogg, A.; Priebel Valera, G.; Lund, C.; Ottiger, H.P.; Gorska, P.; Borensztejn, C.; Pereira, S.; Bousrih, M.; Blumrich, M.; Chapek, M.L.; Ramirez, A.; Thuring, J.; Umiza, A. 2002: Best animal care practices in the production and control of biologicals Developments in Biologicals 111: 221-225
Schulz, V.; Ulmer, W.T.; Kleinsorge, H. 1992: Risk-benefit assessment and value of beta-2-sympathomimetic drugs in asthma therapy Pneumologie 46(8): 315-321
Bekhzadpur, D.; Belousova, R.V.; Ivanov, I.V. 2013: Substantiation of optimum condition of parainfluenza-3 virus cultivation for production of vaccines on the finite cell line Voenno-Meditsinskii Zhurnal 334(4): 27-31
Rios, N.; Adaskina, N.; Frömke, C.; Papendorf, F.; Schippert, C.; Koch, A.; Hillemanns, P.; Park-Simon, T-Won. 2016: The Benefit of Baseline Staging-Risk Assessment of Distant Breast Cancer Metastases by Tumor Stage Anticancer Research 36(9): 4909-4914
Davidson, B.A.; Moorman, P.G. 2014: Risk-benefit assessment of the combined oral contraceptive pill in women with a family history of female cancer Expert Opinion on Drug Safety 13(10): 1375-1382
Jurmanová, K.; Mackatková, M. 1986: Detection of mycoplasmas in cell cultures and biologicals Archiv für Experimentelle Veterinarmedizin 40(1): 136-141
Bergstrom, K.Gail. 2008: Rethinking squamous cell carcinoma: which are high risk, which could benefit from lymph node dissection, what's coming up in the future? Journal of Drugs in Dermatology: Jdd 7(9): 903-906
Buranatrevedh, S. 2010: Health risk assessment of workers exposed to metals from an aluminium production plant Journal of the Medical Association of Thailand 93(Suppl 7): S136-S141
Bektimitov, T.A. 1987: Transforming activity of DNA and proteins in continuous cell cultures and the safety of biologicals Voprosy Virusologii 32(5): 519-524
Meshchakova, N.M.; D'iakovich, M.P.; Shaiakhmetov, S.F.; D'iakovich, O.A.; Telezhkin, V.V. 2014: Risk assessment of health disorders and quality of life in employees of modern polyvinyl chloride production Meditsina Truda i Promyshlennaia Ekologiia 4: 24-29
Sánchez-Marroquín, A. 1971: Sugar cane and agave juices as substrates for the microbiological production of SCP, L-lysine and riboflavin Revista Latinoamericana de Microbiologia 13(2): 107-112
Kurhaliuk, N.M.; Kotsiuruba, A.V.; Sahach, V.F. 2005: The modification of nitric oxide production by exogenous substrates of Krebs cycle during acute hypoxia Fiziolohichnyi Zhurnal 51(4): 20-28
Whittaker, R.; Bramley, D.; Wells, S.; Stewart, A.; Selak, V.; Furness, S.; Rafter, N.; Roseman, P.; Jackson, R. 2006: Will a web-based cardiovascular disease (CVD) risk assessment programme increase the assessment of CVD risk factors for Maori? New Zealand Medical Journal 119(1238): U2077